The company is a UK based global cosmetics and skin care developer with established brands in both traditional anti-ageing and skin health categories. They have strong existing research, product development, regulatory and claims compliance and brand and marketing divisions helping to design and create compelling consumer concepts for the future. Their mission is to help people across the world lead healthier and happier lives. They believe that the health and resilience of people’s skin is vital to this and they are passionate in helping their consumers achieve maximum skin health throughout their lives. Poor skin health can have a significant impact on an individual’s quality of life and can contribute to reductions in both healthspan and lifespan.
There is emerging understanding of the important role that the microbiome plays in the health and resilience of skin, with both the skin microbiome and gut microbiome being implicated. Consumers are beginning to embrace the idea that maintaining a balance between the skin and the microbes that inhabit it is important but are unclear on how this impacts on their individual skin needs and what technologies will be efficacious in this area.
The company is looking to source breakthrough innovations in the diagnosis and maintenance/restoration of consumers individual skin and gut microbiome and its contribution to the performance and status of their skin.
The company is interested in technologies that target 1 or more of the following;
At this time they are not interested in finished products and brands that are looking for retail distribution channels.
Technologies must not be regulated as a drug in either the EU or US
Technologies must not contain any animal derived materials or ingredients.
Technologies that are in proof of concept or early development stages will be lower priority but will still be considered.